~9 spots leftby Apr 2026

Cognitive Processing Therapy for PTSD-BPD

Recruiting at 1 trial location
KM
AG
AG
Overseen ByAriana Guenther, B.A.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Palo Alto University
No Placebo Group
Approved in 4 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial tests a new treatment combining Cognitive Processing Therapy with Suicide Risk Management for people with both PTSD and BPD. The goal is to provide a shorter, more effective treatment that addresses intense emotions and negative thinking patterns. The study will evaluate how well this approach works. Cognitive Processing Therapy (CPT) has been shown to be effective in reducing PTSD symptoms among survivors of sexual assault and other traumas.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, it does not mention a requirement to stay on existing medications either.

What data supports the idea that Cognitive Processing Therapy for PTSD-BPD is an effective treatment?

The available research shows that Cognitive Processing Therapy (CPT) is effective for treating PTSD in veterans, even those at high risk for suicide. In one study, veterans who underwent CPT reported significant reductions in PTSD symptoms, and there were no suicide deaths among patients who received CPT since 2016. Another study found that while more veterans completed an alternative treatment called Seeking Safety, those who completed CPT had greater reductions in PTSD symptoms. This suggests that CPT can be more effective in reducing PTSD symptoms compared to some other treatments.12345

What safety data exists for Cognitive Processing Therapy for PTSD-BPD?

Cognitive Processing Therapy (CPT) has been evaluated for safety in various studies. One study on active duty military personnel found no significant iatrogenic suicide risk associated with group CPT-C. Another study on veterans with PTSD and increased suicide risk showed that CPT was well-tolerated, with no suicide deaths reported since 2016 among those treated. Veterans experienced significant reductions in PTSD symptoms, and suicide risk level did not affect treatment tolerability. Additionally, a comparison study found that while more veterans completed Seeking Safety treatment, those who completed CPT had greater reductions in PTSD symptoms. Overall, CPT is considered safe and effective for individuals with PTSD, including those at increased risk of suicide.12367

Is Cognitive Processing Therapy with Suicide Risk Management a promising treatment for PTSD and BPD?

Yes, Cognitive Processing Therapy with Suicide Risk Management is a promising treatment for PTSD and BPD. It has been shown to help reduce PTSD symptoms in veterans, even those at high risk for suicide. The therapy is well-tolerated and effective, and it can be used safely with individuals who have both PTSD and BPD.12678

Research Team

JR

Janice R Kuo, PhD

Principal Investigator

Palo Alto University

Eligibility Criteria

This trial is for adults aged 18-65 in the Bay Area with PTSD and BPD who are willing to be recorded during sessions. It's not for those with severe comprehension issues, EU residents, life-threatening illnesses, acute mania or psychosis, or intellectual disabilities.

Inclusion Criteria

Must reside in the Bay Area, CA
I have been diagnosed with PTSD and BPD.
Must be willing to be audio- or videorecorded for assessment and treatment sessions
See 1 more

Exclusion Criteria

EU individuals
Severe impairments in written and aural comprehension
I have a severe illness that could be life-threatening.
See 1 more

Treatment Details

Interventions

  • Cognitive Processing Therapy with Suicide Risk Management (Behavioural Intervention)
  • Treatment as Usual with Suicide Rick Management (Behavioural Intervention)
Trial OverviewThe study tests Cognitive Processing Therapy enhanced with Suicide Risk Management (CPT+SRM) against usual treatment plus SRM. Conducted via telehealth over 12 sessions, it aims to improve PTSD-BPD symptoms by targeting emotional intensity and cognitive dysfunction.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: TAU + SRMExperimental Treatment1 Intervention
Participants will be randomized to teletherapy sessions with only Suicide Risk Management for PTSD-BPD which will be administered once a week for 6 weeks, for a total of 6 sessions.
Group II: CPT + SRMExperimental Treatment1 Intervention
Participants will be randomized to teletherapy sessions of Cognitive Processing Therapy + Suicide Risk Management for PTSD-BPD which will be administered twice weekly over 6 weeks, for a total of 12 sessions.

Cognitive Processing Therapy with Suicide Risk Management is already approved in Canada for the following indications:

🇨🇦
Approved in Canada as Cognitive Processing Therapy for:
  • Posttraumatic Stress Disorder (PTSD)
  • Borderline Personality Disorder (BPD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Palo Alto University

Lead Sponsor

Trials
14
Recruited
8,100+

Toronto Metropolitan University

Collaborator

Trials
95
Recruited
19,300+

York University

Collaborator

Trials
64
Recruited
521,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

Ryerson University

Collaborator

Trials
77
Recruited
7,800+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Findings from Research

In a study of 290 military veterans with PTSD, over 50% were identified as having an increased risk of suicide, yet only 1% engaged in suicidal behavior after starting cognitive processing therapy (CPT), indicating that CPT is safe and tolerable for this population.
Veterans with varying levels of suicide risk experienced similar reductions in PTSD symptoms after CPT, suggesting that trauma-focused therapy can be beneficial even for those at higher risk of suicide.
Treating Veterans at Risk for Suicide: An Examination of the Safety, Tolerability, and Outcomes of Cognitive Processing Therapy.Roberge, EM., Harris, JA., Weinstein, HR., et al.[2022]
In a study of 108 active duty US Army personnel with PTSD, both group cognitive processing therapy-cognitive only version (CPT-C) and group present-centered therapy (PCT) significantly reduced rates of suicide ideation, with improvements maintained for up to 12 months post-treatment.
There were no reported suicide attempts during or after treatment in either group, and exacerbation of preexisting suicide ideation was uncommon, suggesting that group CPT-C is safe and does not increase suicide risk among participants.
EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL.Bryan, CJ., Clemans, TA., Hernandez, AM., et al.[2019]
In a study of 420 veterans with PTSD, those receiving Seeking Safety (SS) had a higher treatment completion rate (89%) compared to those receiving cognitive processing therapy (CPT) (50%), indicating SS may be more acceptable for veterans.
However, veterans who completed CPT showed significantly greater reductions in PTSD symptoms, as measured by the PTSD checklist, suggesting that while SS is easier to complete, CPT may be more effective in reducing symptoms.
A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans.Baig, MR., Ouyang, S., Mata-Galán, E., et al.[2021]

References

Treating Veterans at Risk for Suicide: An Examination of the Safety, Tolerability, and Outcomes of Cognitive Processing Therapy. [2022]
EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL. [2019]
A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans. [2021]
Comparing response to cognitive processing therapy in military veterans with subthreshold and threshold posttraumatic stress disorder. [2021]
Predicting suicidal ideation 3 months following intensive posttraumatic stress disorder treatment. [2023]
Effect of Group vs Individual Cognitive Processing Therapy in Active-Duty Military Seeking Treatment for Posttraumatic Stress Disorder: A Randomized Clinical Trial. [2022]
Dissemination and experience with cognitive processing therapy. [2022]
Role of Borderline Personality Disorder in the Treatment of Military Sexual Trauma-related Posttraumatic Stress Disorder with Cognitive Processing Therapy. [2022]